References
- Berthou F., Ratanasavanh D., Riche C., Picart D., Voirin T., Guillouzo A. Comparison of caffeine metabolism by slices, microsomes and hepatocyte cultures from adult human liver. Xenobiotica 1989; 19: 401–417
- Brosen K., Skjelbo E., Rasmussen B. B., Poulsen H. E., Loft S. Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochemical Pharmacology 1993; 45: 1211–1214
- Burke M. D., Thompson S., Elcombe C. R., Halpert J., Haaparanta T., Mayer R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology 1985; 34: 3337–3345
- Butler M. A., Iwasaki M., Guengerich F. P., Kadlubar F. F. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Sciences, USA 1989; 86: 7696–7700
- Campbell M. E., Grant D. M., Inaba T., Kalow W. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Drug Metabolism and Disposition 1987; 15: 237–249
- Clarke S. E., Ayrton A. D., Chenery R. J. Characterization of the inhibition of P4501A2 by furafylline. Xenobiotica 1994; 24: 517–526
- Distlerath L. M., Reilly P. E., Martin M. V., Davis G. G., Wilkinson G. R., Guengerich F. P. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry 1985; 260: 9057–9067
- Fuhr U., Anders E. M., Mahr G., Sorgel F., Staib A. H. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro. Antimicrobial Agents and Chemotherapy 1992; 36: 942–948
- Fuhr U., Doehmer J., Battula N., Wolfel C., Kudla C., Keita Y., Staib A. H. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Biochemical Pharmacology 1992; 43: 225–235
- Grant D. M., Campbell M. E., Tang B. K., Kalow W. Biotransformation of caffeine by microscopes from human liver. Kinetics and inhibition studies. Biochemical Pharmacology 1987; 36: 1251–1260
- Gu L., Gonzalez F. J., Kalow W., Tang B. K. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 1992; 2: 73–77
- Lambert G. H., Kotake A. N., Schoeller D. The CO2 breath tests as monitors of the cytochrome P450 dependent mixed function monooxygenase system. Progress in Clinical and Biological Research 1983; 135: 119–145
- Leakey T. E. Simultaneous analysis of theophylline, caffeine and eight of their metabolic products in human plasma by gradient high-performance liquid chromatography. Journal of Chromatography 1990; 507: 199–220
- Leatherbarrow R. J. Grafit Version 3.0. erithacus Software Ltd Staines. 1992
- Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology 1993; 12: 1–51
- Sesardic D., Boobis A. R., Murray B. P., Murray S., Segura J., De La Torre R., Davies D. S. Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. British Journal of Clinical Pharmacology 1990; 29: 651–663
- Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 1985; 150: 76–85
- Tang-Liu D. D., Williams R. L., Riegelman S. Disposition of caffeine and its metabolites in man. Journal of Pharmacology and Experimental Therapeutics 1983; 224: 180–185
- Tassaneeyakul W., Mohamed Z., Birkett D. J., McManus M. E., Veronese M. E., Tukey R. H., Quattrochi L. C., Gonzalez F. J., Miners J. O. Caffeme as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. Pharmacogenetics 1992; 2: 173–183
- Valero F., De La Torre R., Boobis A. R., Murray S., Segura J. Assay of caffeine metabolism in vitro by human liver microsomes using radio-high-performance liquid chromatography. Journal of Pharmacology and Biomedical Analysis 1990; 8: 783–787